MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma.

MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma.
复制标题

DOI:
10.1186/1471-2407-14-616
复制
发表时间:
2014-08-27
期刊:
影响因子:
3.8
通讯作者:
Zhao RC
Zhao RC
中科院分区:
医学2区
文献类型:
--
作者:
Sun Z;Meng C;Wang S;Zhou N;Guan M;Bai C;Lu S;Han Q;Zhao RC

文献摘要

参考文献

被引文献

相似文献

microRNA 的异常表达已被证明在肝癌的发生和进展中发挥着至关重要的作用。 miR-1246在高侵袭能力细胞系中的表达量显着高于低侵袭能力细胞系。 Transwell小室(8-uM孔径;Costar)用于体外迁移和invison分析。双荧光素酶报告基因构建和双荧光素酶报告基因测定以鉴定 miR-1246 的靶标。通过免疫组织化学染色评估CADM1表达。收集患者的临床表现、治疗情况和生存情况进行统计分析。抑制miR-1246可有效减少肝细胞癌细胞系的迁移和侵袭。生物信息学和荧光素酶报告分析表明,miR-1246 特异性靶向细胞粘附分子 1 的 3'-UTR 并调节其表达。 CADM1 的下调增强了 HCC 细胞系的迁移和侵袭。此外,在肝癌患者的肿瘤组织中,miR-1246的表达与CADM1呈负相关,miR-1246的高表达联合CADM1的低表达可能是1期肝癌患者的危险因素。我们的研究表明,miR-1246 通过下调 CADM1,增强 HCC 细胞的迁移和侵袭。本文的在线版本 (doi:10.1186/1471-2407-14-616) 包含补充材料,可供授权用户使用。
The aberrant expression of microRNAs has been demonstrated to play a crucial role in the initiation and progression of hepatocarcinoma. miR-1246 expression in High invasive ability cell line than significantly higher than that in low invasive ability cell line. Transwell chambers (8-uM pore size; Costar) were used in the in vitro migration and invison anssay. Dual luciferase reporter gene construct and Dual luciferase reporter assay to identify the target of miR-1246. CADM1 expression was evaluated by immunohistochemistric staining. The clinical manifestations, treatments and survival were collected for statistical analysis. Inhibition of miR-1246 effectively reduced migration and invasion of hepatocellular carcinoma cell lines. Bioinformatics and luciferase reporter assay revealed that miR-1246 specifically targeted the 3′-UTR of Cell adhesion molecule 1 and regulated its expression. Down-regulation of CADM1 enhanced migration and invasion of HCC cell lines. Furthermore, in tumor tissues obtained from liver cancer patients, the expression of miR-1246 was negatively correlated with CADM1 and the high expression of miR-1246 combined with low expression of CADM1 might serve as a risk factor for stage1 liver cancer patients. Our study showed that miR-1246, by down-regulation CADM1, enhances migration and invasion in HCC cells. The online version of this article (doi:10.1186/1471-2407-14-616) contains supplementary material, which is available to authorized users.
DOI: 10.1016/j.canlet.2012.11.001
发表时间: 2013-02-28
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Shen, Jun;Stass, Sanford A.;Jiang, Feng
通讯作者: Jiang, Feng
DOI: 10.1002/hep.25695
发表时间: 2012-08-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Chen, Po-Jen;Yeh, Shiou-Hwei;Chen, Pei-Jer
通讯作者: Chen, Pei-Jer
DOI: 10.1016/j.jhep.2010.12.023
发表时间: 2011-09-01
影响因子: 25.7
作者:
Li, Zhen-Ya;Xi, Yang;Liang, Chih-Chuan
通讯作者: Liang, Chih-Chuan
DOI: 10.1002/cncr.21800
发表时间: 2006-04-15
期刊: CANCER
影响因子: 6.2
作者:
Kikuchi, S;Yamada, D;Murakami, Y
通讯作者: Murakami, Y
肝细胞癌患者原发性和复发性肿瘤的肿瘤起始细胞的特性
DOI: 10.1093/carcin/bgp232
发表时间: 2010-02-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Xu, Xiao-Lan;Xing, Bao-Cai;Zhang, Zhi-Qian
通讯作者: Zhang, Zhi-Qian